STOCK TITAN

XMax shareholders approve two stock sales over 20%

The two issuance approvals each covered more than 20% of XMax's issued and outstanding common stock at a price below Nasdaq's defined Minimum Price.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

XMax Inc. shareholders approved four proposals at a special meeting on November 2, 2026: ratification of certain transactions on March 9, March 30 and April 24, 2026, and related common-stock issuances; a private placement issuance; a registered direct offering under an effective Form S-3; and authority for the board chairman to adjourn the meeting to solicit additional proxies.

The private placement and registered direct offering approvals each covered a sale and issuance of more than 20% of XMax's issued and outstanding common stock at a price below the “Minimum Price” defined in Nasdaq Listing Rule 5635(d). Votes for and against were 25,415,770 and 1,047,273 on ratification; 24,235,436 and 2,228,032 on the private placement; 24,235,445 and 2,228,023 on the registered direct offering; and 24,585,804 and 1,877,653 on adjournment.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Ratification proposal — For 25,415,770 votes Votes in favor
Ratification proposal — Against 1,047,273 votes Votes against
Private placement proposal — For 24,235,436 votes Votes in favor
Private placement proposal — Against 2,228,032 votes Votes against
Registered direct offering proposal — For 24,235,445 votes Votes in favor
Registered direct offering proposal — Against 2,228,023 votes Votes against
Adjournment proposal — For 24,585,804 votes Votes in favor
Adjournment proposal — Against 1,877,653 votes Votes against
Ratification regulatory
"Approval of the Ratification"
private placement offering financial
"sale and issuance ... in a private placement offering"
A private placement offering is when a company sells its stock or bonds directly to a small group of investors instead of offering them to the general public. This allows the company to raise money quickly and privately, often for specific projects or needs, without going through a public stock exchange.
registered direct offering financial
"in a registered direct offering under an effective registration statement"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
Minimum Price regulatory
"price lower than the “Minimum Price” as defined in Nasdaq Listing Rule 5635(d)"
The minimum price is the lowest allowable or acceptable price at which a security, share offering, product, or sale can be bought or sold. Think of it like the smallest tag on a store item that the seller will accept; for investors it sets a floor for entry or sale, affects potential returns and liquidity, and can influence demand by limiting purchases below that level.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did XMAX shareholders approve?

XMax shareholders approved ratification of transactions on March 9, March 30 and April 24, 2026, a private placement issuance, a registered direct offering under an effective Form S-3, and authority for the board chairman to adjourn the meeting to solicit additional proxies. Each issuance approval covered more than 20% of issued and outstanding common stock at a price below the defined Minimum Price.

How did XMAX shareholders vote on the issuance proposals?

The private placement received 24,235,436 votes for and 2,228,032 against; the registered direct offering received 24,235,445 votes for and 2,228,023 against. Both proposals had zero abstentions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001473334 0001473334 2026-11-02 2026-11-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 2, 2026

 

XMAX Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   001-36259   90-0746568
(State or Other Jurisdiction   (Commission   (I.R.S. Employer
of Incorporation)   File Number)   Identification No.)

 

6565 E. Washington Blvd., Commerce, CA 90040

(Address of Principal Executive Office) (Zip Code)

 

(323) 888-9999

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   XMAX   The Nasdaq Stock Market LLC

 

 

 

 
 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On November 2, 2026, XMax Inc., a Nevada corporation (the “Company”), held a special meeting of the stockholders (the “Meeting”). A quorum was present at the Meeting and shareholders: (i) approved the ratification of certain transactions on March 9, 2026, March 30, 2026 and April 24, 2026 and related issuances of shares of common stock of the Company (the “Ratification”); (ii) approved, in compliance with Nasdaq Listing Rule 5635(d), the sale and issuance of more than 20% of the Company’s issued and outstanding common stock in a private placement offering at a price lower than the “Minimum Price” as defined in Nasdaq Listing Rule 5635(d) (the “Private Placement Issuance”); (iii) approved, in compliance with Nasdaq Listing Rule 5635(d), the sale and issuance of more than 20% of the Company’s issued and outstanding common stock in a registered direct offering under an effective registration statement on Form S-3 (Registration Number 333-295406) at a price lower than the “Minimum Price” as defined in Nasdaq Listing Rule 5635(d) (the “Shelf Issuance”); and (iv) approved to grant discretionary authority to the Company’s Chairman of the Board of Directors to adjourn the Meeting for the purpose of soliciting additional proxies to approve the above proposals (“Adjournment”).

 

The final voting results of the matters submitted to a shareholder vote at the Meeting are as follows:

 

Proposal 1: Approval of the Ratification

 

For   Against   Abstain
25,415,770   1,047,273   425

 

Proposal 2: Approval of the Private Placement Issuance

 

For   Against   Abstain
24,235,436   2,228,032   0

 

Proposal 3: Approval of the Shelf Issuance

 

For   Against   Abstain
24,235,445   2,228,023   0

 

Proposal 4: Approval of the Adjournment

 

For   Against   Abstain
24,585,804   1,877,653   11

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  XMax Inc.
   
  /s/ Xiaohua Lu
  Xiaohua Lu
  Chief Executive Officer
   
November 4, 2026  

 

 

Filing Exhibits & Attachments

3 documents

Keep reading